# Predictive Value of Osteopontin for Contrast Nephropathy

> **NCT05547581** · — · UNKNOWN · sponsor: **Noura gamal** · enrollment: 155 (estimated)

## Conditions studied

- Contrast-induced Nephropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05547581
- **Lead sponsor:** Noura gamal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-07
- **Primary completion:** 2024-11-05
- **Final completion:** 2024-12-08
- **Target enrollment:** 155 (ESTIMATED)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05547581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05547581, "Predictive Value of Osteopontin for Contrast Nephropathy". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05547581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*